Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04967976

Breast Mesh Used in Two-staged Breast Reconstruction

A Prospective Randomized and Controlled Study of Efficacy and Safety of TiLOOP® Bra Mesh in Patients With Expander-Implant Breast Reconstruction.

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
300 (estimated)
Sponsor
Tianjin Medical University Cancer Institute and Hospital · Academic / Other
Sex
Female
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

This is the first prospective randomized and controlled study on the efficacy and safety of TiLOOP® Bra mesh in patients with expander-implant breast reconstruction. The investigators hypothesize that incoporating TiLOOP Bra mesh with tissue expanders will reduce the rates of capsular contraction, improve the efficiency of expansion and provide better aesthetic result.

Conditions

Interventions

TypeNameDescription
PROCEDURETiLoop Bra mesh in expander-implant breast reconstrutionThe tissue expander is inserted with TiLoop Bra mesh in the first stage of reconstruction immediately after nipple/skin-sparing mastectomy. The tissue expander is placed sub-pectoral.
PROCEDUREsub-pectoral expander-implant breast reconstructionThe tissue expander is inserted without TiLoop Bra mesh in the first stage of reconstruction immediately after nipple/skin-sparing mastectomy. The tissue expander is placed sub-pectoral and covered by muscle/fascia.

Timeline

Start date
2021-08-01
Primary completion
2023-08-01
Completion
2026-08-01
First posted
2021-07-20
Last updated
2021-07-20

Locations

6 sites across 3 countries: United States, China, Germany

Source: ClinicalTrials.gov record NCT04967976. Inclusion in this directory is not an endorsement.